Drug Trial Radar · NCT03728023
A Study of AZD4205 in Healthy Adult Subjects
Last checked: Nov 19, 2026Latest source record: Aug 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
66
Actual
Start
Nov 12, 2018
Primary completion
Aug 20, 2019
Study completion Aug 20, 2019
Sponsor
- Lead sponsor
- Dizal PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Nov 1, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is to assess the safety, tolerability, pharmacokinetics of AZD4205 following single and multiple ascending dose in healthy adult subjects, and to assess the effect of food on the pharmacokinetics of AZD4205.
Conditions
- Healthy Volunteers
Interventions
AZD4205Drug
SAD: 5mg, 20mg, 50mg, 100mg and 150mg MAD: low, medium and high dose once daily X14 days
PlaceboDrug
Single dose in SAD and once daily for 14 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- The number of subjects with adverse eventsTime frame: From screening up to 28 days after last dose (day29 for MAD, day 43 for food effect, day 42 for MAD)
- The number of subjects with abnormal laboratory parametersTime frame: From screening up to 28 days after last dose (day29 for MAD, day 43 for food effect, day 42 for MAD)
- The number of subjects with abnormal vital signsTime frame: From screening up to 28 days after last dose (day29 for MAD, day 43 for food effect, day 42 for MAD)
- The number of subjects with abnormal electrocardiogramTime frame: From screening up to 28 days after last dose (day29 for MAD, day 43 for food effect, day 42 for MAD)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Frontage clinical service
Secaucus, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.